Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …

Introduction: the spread of Acinetobacter baumannii, resistant to most of the available
antimicrobial agents, is a serious health problem. the high rate of carbapenem resistance …

Acinetobacter baumannii is an increasingly common pathogen in healthcare settings
globally. It is frequently resistant to multiple antimicrobial agents and there are recent reports …

Background: Acinetobacter baumannii has emerged as a cause of nosocomial infections in
hospitalized patients, particularly in intensive care units. Carbapenems are a common …

Objectives: Carbapenem resistantAcinetobacter baumannii is an important therapeutic and
infection control challenge worldwide. In this study, we investigated the prevalence and …

Acinetobacter baumannii is a common cause of healthcare-associated infections (HAI)
worldwide, mostly occurring in intensive care units (ICUs). Extended-spectrum beta …

Results: Of 400 samples cultured from ICUs, 15 (3.15%) yielded A. baumannii. A total of 4
isolates (26.6%) were resistant to imipenem (CRAB). Conclusion: Acinetobacter baumannii …

Acinetobacter baumannii has emerged as a problematic multidrug-resistant (MDR)
pathogen worldwide. The aim of this study was to characterize clinical isolates of A …

Objectives This study investigated the prevalence of diverse Ambler class β-lactamase-
encoding genes in 40 carbapenem-insensitive Acinetobacter baumannii isolates collected …

Acinetobacter baumannii has emerged in health care settings as a pandrug-resistant
pathogen. Carbapenems are ineffective for treatment of this pathogen. Here we explored the …